{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_16", "document_index": 84, "latency_s": 0.7780542999971658, "prompt_toks": 6422, "completion_toks": 80, "relevance_score": 3.0590223e-07}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    United States: Cannabidiol is legal under the 2018 Farm Bill[37]. The rest of the cannabis plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.[citation needed]\n\nExternal links\n\nCannabidiol (Wikipedia)\n\nCannabidiol (Isomer Design)\n\nCannabidiol (Drugs-Forum)\n\nProject CBD\n\nLiterature\n\nMechoulam, R., Peters, M., Murillo-Rodríguez, E., & Hanuš, L.O. (2007). Cannabidiol--recent advances. Chemistry & Biodiversity, 4 8, 1678-92.\n\nMechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology, 42(S1).\n\nDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Martinez‐Orgado, J. (2014). Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791-802. https://doi.org/0.1111/epi.12631\n\nReferences\n\n\n                    Context: \n                    This chunk provides information on the legal status of cannabidiol in the United States, highlighting its legality under the 2018 Farm Bill and its classification under Schedule I of the Controlled Substances Act. It also includes external links and key literature references relevant to cannabidiol research and regulation, complementing the overall focus on CBD's effects, safety, and legal considerations within the full document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_26", "document_index": 84, "latency_s": 0.8582372999953805, "prompt_toks": 6423, "completion_toks": 60, "relevance_score": 2.4967014e-07}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Yamaori, Satoshi; Ebisawa, Juri; Okushima, Yoshimi; Yamamoto, Ikuo; Watanabe, Kazuhito (2011). \"Potent inhibition of human cytochrome P450 3A isoforms by cannabidiol: Role of phenolic hydroxyl groups in the resorcinol moiety\". Life Sciences. 88 (15-16): 730–736. doi:10.1016/j.lfs.2011.02.017. ISSN 0024-3205.\n\n↑ Australian Government Department of Health Therapeutic Goods Administration. (2017, August 1). Retrieved from https://www.tga.gov.au/book/part-final-decisions-matters-referred-expert-advisory-committee-2\n\n↑ Consolidated federal laws of Canada, Controlled Drugs and Substances Act\n\n↑ https://hongkongfp.com/2023/02/01/cannabis-compound-cbd-now-banned-in-hong-kong-7-year-jail-term-for-possession-to-match-meth-cocaine/\n\n↑ Medicinal Cannabis Agency - Cannabidiol (CBD) products\n\n↑ Swiss Agency for Therapeutic Products. (2017, August 1). Retrieved from https://www.swissmedic.ch/aktuell/00673/03778/index.html?lang=en\n\n↑ MHRA statement on products containing Cannabidiol (CBD)\n\n\n                    Context: \n                    This chunk consists of references and legal sources related to cannabidiol’s (CBD) inhibition of cytochrome P450 enzymes, international legal classifications, and regulatory bodies' guidelines. It provides supporting citations for sections discussing CBD's pharmacology, legal status, and harm potential within the full webpage.\n                "}
{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_22", "document_index": 84, "latency_s": 0.6165110000001732, "prompt_toks": 6432, "completion_toks": 50, "relevance_score": 1.599447e-07}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    ↑ Devinsky, O., Cilio, M. R., Cross, H., Fernandez-Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras-Aswad, D., Notcutt, W. G., Martinez-Orgado, J., Robson, P. J., Rohrback, B. G., Thiele, E., Whalley, B., Friedman, D. (June 2014). \"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders\". Epilepsia. 55 (6): 791–802. doi:10.1111/epi.12631. ISSN 0013-9580.\n\n↑ \"Epidiolex (Cannabidiol) FDA Label\" (PDF). fda.gov. Retrieved 28 June 2018. For label updates see FDA index page for NDA 210365\n\n↑ Hampson, A. J., Grimaldi, M., Axelrod, J., Wink, D. (7 July 1998). \"Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants\". Proceedings of the National Academy of Sciences. 95 (14): 8268–8273. doi:10.1073/pnas.95.14.8268. ISSN 0027-8424.\n\n\n                    Context: \n                    This chunk provides key scientific references supporting cannabidiol's pharmacological properties, therapeutic potential in neurological disorders, and neuroprotective effects. It highlights studies and regulatory labels essential for understanding CBD’s medical research basis and safety profile within the full document.\n                "}
